Notice: This company has been marked as potentially delisted and may not be actively trading. YS Biopharma (YSB) News Today Add Compare Share Share Headlines Stock AnalysisHeadlinesOwnershipTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 Time Period YS Biopharma (NASDAQ:YS) Hits New 1-Year High - Time to Buy?YS Biopharma (NASDAQ:YS) Reaches New 12-Month High - What's Next?October 3, 2024 | marketbeat.comLakeShore Biopharma Co., Ltd.: LakeShore Biopharma Announces Results of Extraordinary General Meeting on Share ConsolidationOctober 3, 2024 | finanznachrichten.deYS Biopharma (NASDAQ:YS) Trading 7.6% Higher YS Biopharma (NASDAQ:YS) Trading 7.6% HigherSeptember 28, 2024 | marketbeat.comLakeShore Biopharma Co Ltd Ordinary Shares LSBAugust 17, 2024 | morningstar.comLSB LakeShore Biopharma Co., LtdJuly 20, 2024 | seekingalpha.comPieris Pharmaceuticals (NASDAQ:PIRS) Stock Quotes, Forecast and News SummaryJuly 19, 2024 | benzinga.comYS Biopharma (NASDAQ:YS) Stock Price Up 5.3%YS Biopharma (NASDAQ:YS) Stock Price Up 5.3%July 2, 2024 | marketbeat.comYS Biopharma Co., Ltd. (NASDAQ:YS) Sees Large Decline in Short InterestYS Biopharma Co., Ltd. (NASDAQ:YS - Get Free Report) was the recipient of a large drop in short interest in the month of May. As of May 15th, there was short interest totalling 38,900 shares, a drop of 31.4% from the April 30th total of 56,700 shares. Approximately 0.2% of the company's shares are short sold. Based on an average daily volume of 168,600 shares, the short-interest ratio is currently 0.2 days.May 30, 2024 | marketbeat.comYS Biopharma Co., Ltd.: YS Biopharma Announces Name Change to LakeShore BiopharmaMay 24, 2024 | finanznachrichten.deYS Biopharma Announces Name Change to LakeShore BiopharmaMay 24, 2024 | prnewswire.comYS Biopharma Co., Ltd.: YS Biopharma Announces Results of Extraordinary General MeetingMay 22, 2024 | finanznachrichten.deYS Biopharma Announces Results of Extraordinary General MeetingMay 21, 2024 | prnewswire.comYS Biopharma to Hold Extraordinary General Meeting on May 21, 2024 and Announces the Appointment of Interim Chief Executive OfficerMay 7, 2024 | prnewswire.comWith 80% ownership, YS Biopharma Co., Ltd. (NASDAQ:YS) insiders have a lot riding on the company's futureMay 7, 2024 | finance.yahoo.comYS Biopharma Co., Ltd.: YS Biopharma Receives Additional 180 Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price RuleApril 29, 2024 | finanznachrichten.deYS Biopharma Receives Additional 180 Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price RuleApril 29, 2024 | prnewswire.comFY2024 EPS Estimates for YS Biopharma Co., Ltd. (NASDAQ:YS) Lowered by AnalystYS Biopharma Co., Ltd. (NASDAQ:YS - Free Report) - Equities researchers at Diamond Equity decreased their FY2024 earnings per share estimates for shares of YS Biopharma in a research note issued to investors on Monday, April 22nd. Diamond Equity analyst H. Diamond now anticipates that the companyApril 25, 2024 | marketbeat.comYS Biopharma Co., Ltd. (NASDAQ:YS) Q3 2024 Earnings Call TranscriptApril 22, 2024 | finance.yahoo.comYS Biopharma Co., Ltd.: YS Biopharma Announces Unaudited Financial Results for the First Nine Months of Fiscal Year 2024April 19, 2024 | finanznachrichten.deYS Biopharma Co., Ltd.: YS Biopharma Announces Unaudited Financial Results for the First Nine Months of Fiscal Year 2024April 19, 2024 | finanznachrichten.deYS Stock Earnings: YS Biopharma Co Misses EPS, Beats Revenue for Q3 2024April 19, 2024 | markets.businessinsider.comYS Biopharma Announces Unaudited Financial Results for the First Nine Months of Fiscal Year 2024April 19, 2024 | prnewswire.comYS Biopharma Co., Ltd.: YS Biopharma Granted Phase I Clinical Trial License of Therapeutic Chronic Hepatitis B Virus VaccineApril 18, 2024 | finanznachrichten.deYS Biopharma Granted Phase I Clinical Trial License of Therapeutic Chronic Hepatitis B Virus VaccineApril 18, 2024 | prnewswire.comYS Biopharma to Report First Nine Months of Fiscal Year 2024 Financial Results on April 19, 2024April 16, 2024 | finance.yahoo.comChinese Biotech YS Biopharma's Next-Gen Rabies Vaccine Non-Inferior To Approved CompetitorApril 9, 2024 | msn.comYS Biopharma Co., Ltd.: YS Biopharma Announces Positive Interim Results of Pivotal Phase 3 Clinical Study of PIKA Rabies VaccineApril 9, 2024 | finanznachrichten.deYS Biopharma Announces Positive Interim Results of Pivotal Phase 3 Clinical Study of PIKA Rabies VaccineApril 9, 2024 | finance.yahoo.comYS Biopharma Announces Positive Interim Results of Pivotal Phase 3 Clinical Study of PIKA Rabies VaccineApril 9, 2024 | prnewswire.comYS Biopharma Announces Full Repayment of US$40,000,000 Loan FacilityApril 3, 2024 | finance.yahoo.comTechnology and demographics affect hiring and pay strategiesMarch 28, 2024 | msn.comYS Biopharma Co., Ltd.: YS Biopharma Announces Board Changes and Strategic Leadership Appointments in Chinese SubsidiariesMarch 5, 2024 | finanznachrichten.deYS Biopharma Announces Board Changes and Strategic Leadership Appointments in Chinese SubsidiariesMarch 5, 2024 | finance.yahoo.comYS Biopharma Announces Results of Extraordinary General Meeting held on February 22, 2024February 22, 2024 | finance.yahoo.comYS Biopharma Co., Ltd.: YS Biopharma Announces Results of Extraordinary General Meeting and Responds to False Statements about the MeetingFebruary 17, 2024 | finanznachrichten.deYS Biopharma Announces Results of Extraordinary General Meeting and Responds to False Statements about the MeetingFebruary 17, 2024 | finance.yahoo.comYS Biopharma Announces Results of Extraordinary General Meeting and Responds to False Statements about the MeetingFebruary 16, 2024 | prnewswire.comShareholders Led by Yi Zhang Announce Successful Results of Removal of Directors and Election of New Directors of YS Biopharma Co., Ltd.February 16, 2024 | finance.yahoo.comShareholders Led by Yi Zhang Announce Successful Results of Removal of Directors and Election of New Directors of YS Biopharma Co., Ltd.February 16, 2024 | prnewswire.comYS Biopharma Announces Appointment of New DirectorsFebruary 14, 2024 | finance.yahoo.comYS Biopharma to Hold an Extraordinary General Meeting on February 22, 2024 pursuant to a Shareholder Requisition to Enhance Corporate GovernanceFebruary 14, 2024 | finance.yahoo.comYS Biopharma to Hold an Extraordinary General Meeting on February 22, 2024 pursuant to a Shareholder Requisition to Enhance Corporate GovernanceFebruary 14, 2024 | prnewswire.comYS Biopharma Announces Appointment of New DirectorsFebruary 14, 2024 | prnewswire.comYS Biopharma Responds to a Notice of Extraordinary General Meeting of Shareholders of YS Biopharma Co., Ltd.February 12, 2024 | finance.yahoo.comYS Biopharma Announces US$40 Million Private Placement FinancingFebruary 9, 2024 | finance.yahoo.comShareholders of YS Biopharma Announce an Extraordinary General MeetingFebruary 8, 2024 | finance.yahoo.comYS Biopharma Co., Ltd.: YS Biopharma Announces Unaudited Financial Results for the First Half of Fiscal Year 2024January 24, 2024 | finanznachrichten.deYS Biopharma Announces Unaudited Financial Results for the First Half of Fiscal Year 2024January 22, 2024 | finance.yahoo.comYS Biopharma Announces Changes to its Board CommitteesJanuary 8, 2024 | finance.yahoo.comYS Biopharma Says Fake Press Release Called for Extraordinary General MeetingDecember 20, 2023 | marketwatch.com Remove Ads Get YS Biopharma News Delivered to You Automatically Sign up to receive the latest news and ratings for YSB and its competitors with MarketBeat's FREE daily newsletter. Email Address YSB Media Mentions By Week YSB Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. YSB News Sentiment▼0.000.78▲Average Medical News Sentiment YSB News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. YSB Articles This Week▼01▲YSB Articles Average Week Remove Ads Get YS Biopharma News Delivered to You Automatically Sign up to receive the latest news and ratings for YSB and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Dyne Therapeutics News Today Ocular Therapeutix News Today Ardelyx News Today Indivior News Today Amphastar Pharmaceuticals News Today ANI Pharmaceuticals News Today Iovance Biotherapeutics News Today Evotec News Today Calliditas Therapeutics AB (publ) News Today Structure Therapeutics News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:YSB) was last updated on 3/12/2025 by MarketBeat.com Staff From Our PartnersURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredFormer CIA to Trump – Will you Shut down this secret lab?Deep in the sands of New Mexico lies a government lab so secret it makes Area 51 look like a tourist spot… ...Paradigm Press | SponsoredDeFi Coin on Verge of Breakout!We’re Opening the Ultimate Crypto Vault… Don't let this be the missed opportunity you regret for years. Crypto 101 Media | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredTrump doesn’t give a damnPorter Stansberry: “I met with Trump’s biggest backers… they’re scooping up these 10 stocks” I recently met...Porter & Company | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredUrgent Bitcoin alert for RIGHT NOWFormer billion-dollar hedge fund manager Larry Benedict has released the most incredible presentation of his 4...Brownstone Research | SponsoredTrump’s Victory Could Spark Major Gains for Gold – Don’t Miss Out This "Patriot's Tax Shield" lets you defend your wealth with real, solid gold. Our exclusive, free wealth pr...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding YS Biopharma Co., Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share YS Biopharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free YSB Stock Alerts